targeted therapy
Showing 1 - 25 of >10,000
Chemotherapy Alone Versus Chemotherapy Plus Targeted Therapy as
Completed
- Colorectal Cancer Metastatic
- Targeted agent
- (no location specified)
Aug 31, 2023
Efficacy of Targeted Therapy for NSCLC
Recruiting
- Evaluation
- +2 more
- RecistTM criteria
-
Chongqing, Chongqing, ChinaCancer Center, Dapping Hospital, Army Medical Center of PLA
Nov 15, 2023
Pulmonary Hypertension Trial
Not yet recruiting
- Pulmonary Hypertension
- (no location specified)
Nov 12, 2023
Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR
Completed
- Metastatic Colorectal Adenocarcinoma
- (no location specified)
Oct 9, 2023
Heart Transplant Rejection Trial in Helsinki (Cell-free DNA)
Recruiting
- Heart Transplant Rejection
- Cell-free DNA
-
Helsinki, Uusimaa, FinlandHelsinki University Hospital
Oct 2, 2023
Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)
Not yet recruiting
- Polycystic Ovary Syndrome
- laparoscopy / laparotomy
- NO INTERVENTION
-
Hyderabad, Telangana, IndiaDr. Shraddha Ramchandani
Oct 25, 2023
Anaplastic Thyroid Cancer Trial in Leiden (dabrafenib/trametinib)
Recruiting
- Anaplastic Thyroid Cancer
-
Leiden, Zuid-Holland, NetherlandsEllen Kapiteijn
Oct 5, 2023
HER2-positive Breast Cancer Trial (Standard of Care Adjuvant Breast Radiation, Standard of Care HER2-targeted Therapy Without
Not yet recruiting
- HER2-positive Breast Cancer
- Standard of Care Adjuvant Breast Radiation
- Standard of Care HER2-targeted Therapy Without Adjuvant Breast Radiation
- (no location specified)
Jan 20, 2023
Immunotherapy and Targeted Therapy for Advanced Soft Tissue
Recruiting
- Advanced Soft Tissue Sarcoma
-
Beijing, Beijing, ChinaDepartment of Medical Oncology, Peking Union Medical College Hos
Sep 25, 2023
Obstructive Sleep Apnea Trial in La Jolla (Eszopiclone 2 mg, Placebo)
Not yet recruiting
- Obstructive Sleep Apnea
- Eszopiclone 2 mg
- Placebo
-
La Jolla, CaliforniaUC San Diego; Altman Clinical and Translational Research Institu
Jul 10, 2023
Healthcare Resource Utilization and Costs of Immune Checkpoint
Completed
- Melanoma
-
East Hanover, New JerseyNovartis
May 12, 2023
Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
- +4 more
-
Guangzhou, Guangdong, ChinaSUN Yat-sen University Cancer Center
Sep 11, 2023
/or PD-1 Inhibitors for Unresectable Intrahepatic
Completed
- Intrahepatic Cholangiocarcinoma
- hepatic arterial infusion chemotherapy (HAIC) of oxaliplatin, fluorouracil, and leucovorin (FOLFOX)
-
GuangZhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 7, 2022
Results of Specific Gene Testing and Efficacy of Targeted
Completed
- Non Small Cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Mar 27, 2023
Pediatric Cancer Trial in Eldoret (Vincristine)
Recruiting
- Pediatric Cancer
-
Eldoret, Rift Valley, KenyaMoi Teaching and Referral Hospital
Apr 25, 2023
Colorectal Cancer, Chemo Effect Trial in GuangZhou (FOLFOX chemo regimens, Bevacizumab)
Not yet recruiting
- Colorectal Cancer
- Chemotherapy Effect
- FOLFOX chemotherapy regimens
- Bevacizumab
-
GuangZhou, Guangdong, ChinaThe Sixth Affiliate Hospital of Sun Yat-Sen University
Apr 3, 2023
Liver Transplantation, Hepatocellular Carcinoma Trial in Guangzhou (FOLFOX-HAIC, Lenvatinib, PD-1 inhibitor)
Not yet recruiting
- Liver Transplantation
- Hepatocellular Carcinoma
- FOLFOX-HAIC
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital, Sun Yat-sen University
Jul 26, 2022
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Low Dose Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Cardiotoxicity, HER2-positive Breast Cancer, Heart Failure Trial in London (Phased withdrawal of heart failure medications)
Not yet recruiting
- Cardiotoxicity
- +3 more
- Phased withdrawal of heart failure medications
-
London, United Kingdom
- +1 more
May 19, 2023
NSCLC Trial (disease self-management application)
Not yet recruiting
- Non-small Cell Lung Cancer
- disease self-management application
- (no location specified)
Nov 9, 2022
Nursing Caries, Gastrointestinal Stromal Tumors Trial in Nanjing (integrated care mode, conventional care mode)
Recruiting
- Nursing Caries
- Gastrointestinal Stromal Tumors
- integrated care mode
- conventional care mode
-
Nanjing, Jiangsu, ChinaNanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing
Dec 17, 2022
Rheumatoid Arthritis, Insufficient Response to Methotrexate or Leflunomide Trial in Strasbourg (Methotrexate + targeted therapy
Recruiting
- Rheumatoid Arthritis
- Insufficient Response to Methotrexate or Leflunomide
- Methotrexate + targeted therapy administration
- methotrexate or leflunomide + sulfasalazine + hydroxychloroquine administration
-
Strasbourg, FranceHôpitaux Universitaires de Strasbourg
Jul 8, 2022
Young Patients With Early Breast Cancer
Not yet recruiting
- Breast Cancer Female
- operation
- (no location specified)
Sep 6, 2023